Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Zynex Inc

ZYXI
8,33
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/11/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202414:20EDGAR2Form 144 - Report of proposed sale of securities
30/10/202417:01EDGAR2Form 144 - Report of proposed sale of securities
29/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202423:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/202422:15EDGAR2Form 8-K - Current report
24/10/202422:01PRNUSZynex Reports Third Quarter 2024 Financial Results
16/10/202415:15PRNUSZynex Sets Third Quarter 2024 Earnings Call
06/9/202400:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202415:15PRNUSZynex to Present at the HC Wainwright Global Investment..
03/9/202415:15PRNUSZynex Obtains FDA clearance for new Pain Management Device
09/8/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202415:00EDGAR2Form 144 - Report of proposed sale of securities
25/7/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202422:15EDGAR2Form 8-K - Current report
25/7/202422:01PRNUSZynex Reports Second Quarter 2024 Financial Results
17/7/202415:15PRNUSZynex Sets Second Quarter 2024 Earnings Call
11/7/202415:15PRNUSZynex Recognized as a Best Company to Work For by U.S. News..
10/6/202415:30PRNUSZynex to Participate in Fireside Chat with RBC Capital..
06/6/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202423:24EDGAR2Form 8-K - Current report
09/5/202415:15PRNUSZynex to Present at the RBC Capital Markets Global..
07/5/202415:15PRNUSZynex Executives Recognized Among Top 25 in Medical..
30/4/202422:01PRNUSZynex Reports First Quarter 2024 Financial Results
18/4/202415:15PRNUSZynex Sets First Quarter 2024 Earnings Call
02/4/202415:15PRNUSZynex Earns Prestigious 2024 Top Workplaces USA Employer..
29/2/202422:15EDGAR2Form 8-K - Current report
29/2/202422:01PRNUSZynex Reports Fourth Quarter and Full Year 2023 Financial..
22/2/202415:15PRNUSZynex Sets Fourth Quarter and Full Year 2023 Earnings Call
20/2/202415:15PRNUSZynex Introduces New Products
08/2/202415:00GLOBESichenzia Ross Ference Carmel LLP Closes Over 100 Capital..
06/2/202415:15PRNUSZynex Receives FDA Clearance for its Next Generation NMES..
02/2/202415:15PRNUSZynex Recognized in Top 25 Medical Device Companies for 2024
29/1/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202415:15PRNUSZynex to Participate at the Needham Annual Growth Conference
05/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 8,33

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network